|
|
 |
|
Viewing report
|
|
|
|
Duchenne Muscular Dystrophy: Advances in Therapeutics
Informa Healthcare, Feb 2006, Pages: 496
Duchenne Muscular Dystrophy (DMD) is one of the most prevalent genetic disorders of childhood and currently stands as an incurable condition. This authoritative guide provides a clear overview of the latest current and experimental approaches to the treatment of DMD and examines the clinical, genetic, and pathophysiological aspects of the disease in the context of emerging therapeutic modalities. The only available source on the subject, this reference emphasizes the importance of accurate diagnosis, carrier detection, and genetic counseling, and supplies state-of-the-art contributions on pharmacological interventions, regenerative medicine, and gene therapy.
Customers who bought this item also bought
Molecular Diagnostics - Technologies, Markets and Companies
Nitric Oxide - Therapeutics, Markets and Companies
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
Opportunities in Noninvasive Prenatal Diagnostics and Newborn Screening
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
Future Japanese Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
|
|
|
|
